
ABOUT US
Cytiva provides the expertise and tools spanning a wide range of applications from basic research of proteins and cells to large-scale purification of biopharmaceuticals. Within the bioprocessing space, Cytiva provides products and expertise for developers and manufacturers of biotherapeutics to enable efficient, flexible and cost-effective approaches to characterization, expression and purification of biomolecules. The company offers tools and support to take recombinant proteins, monoclonal antibodies, plasma proteins, oligonucleotides and vaccines from research, through process development, to full-scale manufacturing. Cytiva has a "healthymagination" vision for the future to improve quality, decrease costs and increase access to better healthcare around the world.
Bioprocessing: cell culture, chromatography and filtration solutions, and analytics
Cytiva's portfolio encompasses both upstream and downstream processing and includes solutions for large-scale production as well as tools for process development, Quality by Design, analytical analysis and flexible manufacturing. Some key product areas are listed below:
- ReadyToProcess™ - a platform of ready to use, and single use, flexible-manufacturing equipment, includes WAVE Bioreactor™ systems and Cellbag™ single-use cell culture bioreactors.
- Xcellerex™ - a single-use technologies platform including XDR bioreactors, XDM Quad Mixers, and related single-use assemblies
- PreDictor™ 96-well plates and PreDictor RoboColumn™ units for process development of chromatography separations
- ULTA™ filters for sterile filtration and clarification applications
- MabSelect SuRe™ LX, the Capto™ media family; and Capto ImpRes all modern BioProcess™ media for all phases of purification
- ÄKTA™ systems for all scales of chromatography and filtration
- AxiChrom™ chromatography columns
- Technical support, and training through Fast Trak services
Cytiva's products enable improvements in process efficiency through optimized performance, advanced automation, integrated unit operations, and technical support. These solutions allow agile manufacturing with shortened development times and excellent facility utilization. The company offers complete start-to-finish solutions in a range of areas such as monoclonal antibodies, plasma proteins, oligonucleotides and vaccines, and is continuously developing its range of products and services.
Additionally, Cytiva has a range of products for characterization and analysis of biomolecular interactions and biomolecule stability, including Biacore™ SPR and MicroCal™ DSC systems.
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED PRODUCTS
- Hyclone Cell Boost Supplements
- HyClone Cell Culture Media, Sera And Process Liquids
- Label-Free Interaction Analytics
- Cell Culture Device: ReadyToProcess WAVE™ 25 Bioreactor System
- Single-Use, Flexible Stirred-Tank Bioreactor System: Xcellerex XDR-10
- Single-Use Anion Exchange Membranes: ReadyToProcess™ Adsorber Q
- Liquid Chromatography System For Scale-Up Biomanufacturing: ÄKTA
- Evaluation For Ultrafiltration To High Protein Concentration Using TFF
FEATURED ARTICLES
- Lessons From The Bone Therapeutics/Medsenic Merger
- TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
- BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko
- BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.
- Challenges Of The IVT Reaction In mRNA Production
- How To Maintain A Nuclease Free Environment During mRNA Production
- How To Choose A Capping Method In MRNA Production
- BoB@JPM: Post-IPO With Bolt Bio Drs. Randall Schatzman and Edith Perez
- Simplify Bioprocess Data Collection With FlexFactory™ Historian
- Key Components And Functions Of The ÄKTA oligosynt™ Synthesizer
- Small-Scale Oligonucleotide Synthesizer For Research And Process Development
- LNP Formulation For mRNA delivery
- mRNA Product Purification Process Strategies
- mRNA Product IVT Process Insights
- mRNA: Challenges And Strategies Related To The DNA Template Process
- Introduction To mRNA Manufacturing
- BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.
- A Guide To Polishing Chromatography In Process Development
- BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
- Using Mathematical Models To Improve Process Development
- Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
- Understanding The Oligonucleotide Synthesis Process
- Biopharma Resilience: Addressing Manufacturing And Talent Needs
- Biopharma Resilience: Building Biomanufacturing Capacity
- How Distributed Automation And DPM Support Resilient Biomanufacturing
- Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed
- Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
- rAAV Production Using HEK293 Cell Line And Transfection Medium
- Establishing A Robust Workflow To Identify High-Performing Clones
- Computational Drug Discovery With Gain Therapeutics' Matthias Alder
- Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
- AI & Computational Biology With Recursion's Chris Gibson, Ph.D.
- Financing Biopharma Innovation With Allan Shaw
- Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D.
- Pursuing A “Biologic Revolution” With Vaxxinity’s Mei Mei Hu
- The Antibody Engine With Abpro's Chan Brothers
- Longhorn’s Path To A Universal Influenza Vaccine
- Epigenomic Programming With Omega Therapeutics’ Mahesh Karande
- In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.
- RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati
- Capture Of Bispecific Antibodies And Removal Of Product-Related Impurities
- Generating A Robust Host Cell Line For A Cell Line Development Platform
- Making Medicine From Tick Spit: Akari Therapeutics' Rachelle Jacques
- The Road To Reality For Allogeneic Cell Therapy
- Product vs. Platform With Surface's Vito Palombella, Ph.D. And Robert Ross, M.D.
- Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth
- How Biopharma Can Address Specialized Skills Gaps And Improve Resilience
- Standardization And Flexibility In Aseptic Filling
- Engineering Proteins For Food Allergies With Ukko's Dr. Anat Binur
- Saudi Arabia Government Leaders Discuss Agile Manufacturing Beyond Borders
- Addressing Rapid Biomanufacturing Capacity Needs
- Biopharma Resilience: CDMOs Secure Supply Chain Management
- 5 Translational Research Challenges On The Path To Patients
- Oncology Discovery Advances With AbbVie's Steve Davidsen, Ph.D.
- Investments, Capacity Expansion, And Improvements
- Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility Needs
- IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.
- Dry Powdered Medium Milling Equivalency Study
- Origin Equivalence Study: HyClone Characterized Fetal Bovine Serum (FBS)
- What Makes A High-Quality Chromatography Resin?
- Regenerative Wound Care With BioStem Technologies
- From Discovery To Commercial Promise With Philogen’s Dr. Dario Neri
- Epigenomic Programming With Omega Therapeutics' Mahesh Karande
- IDO Target Perseverence With IO Biotech's Mai-Britt Zocca, Ph.D.
- Pursuit Of A Universal Flu Vaccine With Longhorn Vaccines & Diagnostics' Jeff Fischer
- Genetic Testing & Neurodegenerative Disorders With AviadoBio's Lisa Deschamps
- Biotech M&A Anomalies With Allan Shaw
- Rethinking Cancer Treatment With Anixa’s Amit Kumar
- Gene Therapies For Better Kidney Treatments With Purespring Therapeutics
- Observations On Outsourcing With Molecule To Market's Raman Sehgal
- Pursuing Aggressive Advocacy With SparingVision’s Stéphane Boissel
- Pursuing Venture Philanthropy With Opus Genetics: The Business Of Biotech
- Pursuing Hybrid Funding Models With Silence Therapeutics’ Craig Tooman
- What's A Biologic Revolution? With Vaxxinity's Mei Mei Hu, J.D.
- Fed Funding: Creative Capital Generation With James Thomas Coates, Ph.D.
- Oligonucleotide Opportunities in DMD with PepGen's James McArthur, Ph.D.
- Surface Plasmon Resonance (SPR): Visualize Your Research
- Biotin CAPture Kit Ready-To-Go Interaction Analysis
- Outstanding Sensitivity For Confident SPR Interaction Analysis
- Explore Protein Interactions Beyond Affinity To Boost Your Academic Research
- The Critical Role Of CDMOs In Driving Biomanufacturing Resilience
- Diabetes: Changing The Insulin Paradigm
- Cytiva Expanding US Operations
- Innate Immunity & Mouse Models With LIfT Biosciences' Alex Blyth
- Antibody Cocktails With Immunome's Dr. Purnanand Sarma
- Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri
- Simplify Bioreactor Scale Up And Scale Down
- Fibroblasts In Regenerative Medicine With Pete O'Heeron & Dr. Hamid Khoja
- mRNA Manufacturing: Overcoming CMC Development Challenges
- New To mRNA Manufacturing? Considerations For Starting
- Lara Sullivan, M.D. On Site-Specific ADCs, Change Management
- The Biotech Beatdown With Allan Shaw
- Inflammation & Antibodies With Ampio Pharmaceutical's Mike Martino, CEO
- Navigating The Diverse Antibody Pipeline With Chromatography Innovations
- Fluid Flow Effects In A Chromatography Column For Mechanistic Models
- Downstream Digital Twins. Biopharma Going In Silico
- What's Next For COVID Vaccines: Tonix Pharmaceuticals' Seth Lederman, M.D.
- Mechanistic Chromatography Modeling - Infographic
- Regulatory Convergence With Aurion Biotech
- Running Interference: RNAi With Silence Therapeutics' Craig Tooman
- Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
- Optimize Antibody Fragment Purification
- Optimization Of A Two-Step Purification Method For Bispecific Antibodies
- Gene Tx For Renal Disease With Purespring CEO Richard Francis
- High Quality Resins Manufacturing During A Pandemic And Beyond
- Improving Biomanufacturing Resilience In An Uncertain Future
- Demonstrating ROI For Increased Digital Plant Maturity
- Fighting Blindness & Funding The Fight With Opus Genetics' Ben Yerxa, CEO
- Supporting The Global Biopharma Industry With Single-Use Capacity Expansion
- Gynecological Cancer Therapies With Context Therapeutics' Martin Lehr
- Strategies For Scaling Up mRNA Manufacturing
- Commensal Viral Vectors With Ring Therapeutics' Tuyen Ong, M.D.
- Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.
- mRNA Manufacturing: In House Or Outsourced?
- Regulatory Concerns In mRNA Therapeutic Development
- CMC Considerations For mRNA Manufacturing
- A Q&A On CMC In mRNA Manufacturing
- Oligonucleotide Development And Manufacturing Workflow
- SparingVision's Stéphane Boissel On Insourcing Bio Talent & IP
- Biotech M&A Trends With Allan Shaw
- Outsourcing Process Dev: Key Considerations For Biopharma
- The Market For mRNA Vaccines & Therapeutics
- Three Leaders In mRNA Therapeutics
- Process Development Challenges In mRNA Therapeutics
- Addressing mRNA’s Scalability And Supply Challenges
- LNP Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.
- Intensification Strategies For Upstream, Downstream Processes
- Strategies, Emerging Technologies For mAb Capture
- CAR T-Cells Therapies Get Closer To Solid Tumor Application
- AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D
- Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago
- Biacore™ SPR System Fact Or Fiction Series
- Is The Sensitivity Of Optical Biosensors Important?
- Can Kinetics Provide Detailed Information About Binding Interactions?
- Is Evaporation Important For Optical Biosensors?
- Can You Run Crude Samples Using An SPR Instrument?
- High-Throughput mAb Purification With Fibro Chromatography
- BioProcess Automation ROI And Next Steps
- The Incremental Approach To BioProcess Automation Adoption
- Technical Implications, Cost Considerations Of BioProcess Automation
- Who Champions Process Automation, And Who Runs It?
- What Motivates A Process Automation Investment?
- BioProcess Automation: Three Leaders On Where They Stand
- Plant-Based Biologics With iBio's Randy Maddux
- NK Cell Therapy Accessibility Ft. Dr. Kleanthis Xanthopoulos
- A Hybrid mAb Manufacturing Model With John Glasspool
- In-House Manufacturing: Key To Driving A Diabetes Vaccine?
- Biotech Capital Markets Forecast With Allan Shaw
- Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias
- Genomic Medicine And The Tools To Realize Its Potential